A
Ambulatorium Sp. z o.o. | Ambulatorium Sp. z o.o. - Elblag, Poland
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Guselkumab
TAK-279
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 2 total trials
The purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) axial disease by...
Enrolling
Arthritis, Psoriatic
Drug: Placebo
Drug: Guselkumab
The main aim of this study is to check the side effects of TAK-279 and how well it is tolerated in participants with moderate-to-severe plaque psoria...
Enrolling
Plaque Psoriasis
Drug: TAK-279
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems